Today's Top 5
5. Policy and Regulatory Conference Coverage
Great to see the attention to #cancerpolicy and #regulatory aspects at #ESMO20. Very interesting study by @KNVokinger assessing differences between the @FDAOncology and @EMA_News in level of evidence required for regulatory approval. https://t.co/uhdq1qT9Aj pic.twitter.com/YI6xf2yySM
— Esther Broekman (@BroekmanEsther) September 21, 2020
4. The Pandemic’s Long-term Effects
“We need to think now about the long-term effects of this pandemic and how we can prevent it from happening again… There are questions to be asked that I don’t see being asked.”–@TheLongSOM’s Robert Hromas on whether the health-care system can recover https://t.co/EJNZLUP5Z3
— ASH Clinical News (@ASHClinicalNews) September 23, 2020
3. Panel: Cancer Research and COVID-19
Tune in tomorrow at 11 am ET for a special panel on cancer research and COVID-19 and Cancer featuring @AACRPres Dr. Antoni Ribas. Learn more: https://t.co/hJwTpUJZ49 #WorldCancerResearchDay pic.twitter.com/kBUPCxXiN8
— AACR (@AACR) September 23, 2020
2. Pancreatic Cancer Cure
"We are beyond the idea of surgery curing pancreatic cancer. It isn't just a surgical approach, it is radiation oncology, medical oncology, basic science, it's a team. And this team approach is what will bring us closer to a cure." - Dr. @SanjaySReddy @pancanphilly https://t.co/RO8sbKhFe9
— Fox Chase Cancer Center (@FoxChaseCancer) September 24, 2020
1. Sickle Cell Research
HRI depletion cooperates with pharmacologic inducers to elevate fetal hemoglobin and reduce sickle cell formation https://t.co/EF4GHcTwJX pic.twitter.com/IXU6gwwJMp
— Blood Advances (@BloodAdvances) September 24, 2020